An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins
about
TCR-Engineered T Cells Meet New Challenges to Treat Solid Tumors: Choice of Antigen, T Cell Fitness, and Sensitization of Tumor MilieuA new antigen recognized by cytolytic T lymphocytes on a human kidney tumor results from reverse strand transcriptionImmunomic analysis of human sarcomaA post-translational modification of nuclear proteins, N(G),N(G)-dimethyl-Arg, found in a natural HLA class I peptide ligandAn N-acetylated natural ligand of human histocompatibility leukocyte antigen (HLA)-B39. Classical major histocompatibility complex class I proteins bind peptides with a blocked NH(2) terminus in vivoProgress and controversies in developing cancer vaccines.Database of T cell-defined human tumor antigens: the 2013 updateDNA vaccine for cancer immunotherapyImmunoproteomics: Mass spectrometry-based methods to study the targets of the immune responseGenome-wide association analyses identify 13 new susceptibility loci for generalized vitiligoThe cytoplasmic peptide:N-glycanase (NGLY1) - Structure, expression and cellular functionsMass-spectrometric evaluation of HLA-A*0201-associated peptides identifies dominant naturally processed forms of CTL epitopes from MART-1 and gp100.Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: implications for tumor immunotherapyPhosphorylated peptides are naturally processed and presented by major histocompatibility complex class I molecules in vivoExtended O-GlcNAc on HLA Class-I-Bound Peptides.Immunologic hierarchy, class II MHC promiscuity, and epitope spreading of a melanoma helper peptide vaccine.Tolerogenic properties of lymphatic endothelial cells are controlled by the lymph node microenvironment.Mechanisms of spatial and temporal development of autoimmune vitiligo in tyrosinase-specific TCR transgenic mice.Evaluation of the sentinel immunized node for immune monitoring of cancer vaccinesStrategies and challenges in eliciting immunity to melanoma.N-glycosylation enhances presentation of a MHC class I-restricted epitope from tyrosinaseIdentification of a 17beta-hydroxysteroid dehydrogenase type 12 pseudogene as the source of a highly restricted BALB/c Meth A tumor rejection peptide.gp100/pmel17 and tyrosinase encode multiple epitopes recognized by Th1-type CD4+T cells.The class I antigen-processing pathway for the membrane protein tyrosinase involves translation in the endoplasmic reticulum and processing in the cytosolThe contributions of mass spectrometry to understanding of immune recognition by T lymphocytes.Tumor antigens and tumor vaccines: peptides as immunogens.Contribution of mass spectrometry to contemporary immunology.Proteomics in cancer vaccine development.Rapid and sensitive identification of major histocompatibility complex class I-associated tumor peptides by Nano-LC MALDI MS/MS.Relating TCR-peptide-MHC affinity to immunogenicity for the design of tumor vaccinesN-linked glycosylation does not impair proteasomal degradation but affects class I major histocompatibility complex presentation.Vitiligo puzzle: the pieces fall in place.Free oligosaccharides to monitor glycoprotein endoplasmic reticulum-associated degradation in Saccharomyces cerevisiaeComparative quantitative mass spectrometry analysis of MHC class II-associated peptides reveals a role of GILT in formation of self-peptide repertoirePathways of antigen processing.Human tumor antigens for cancer vaccine development.Proteolysis and class I major histocompatibility complex antigen presentation.The role of endoplasmic reticulum-associated protein degradation in MHC class I antigen processing.Activated antigen-presenting cells select and present chemically modified peptides recognized by unique CD4 T cells.T-cell recognition of melanoma-associated antigens.
P2860
Q21131200-1C8735B9-7F52-424C-A199-77F795B9B1D9Q22010943-E7829966-2B58-469E-9831-A359513828C8Q24554211-78B64446-D072-4139-AA59-B4243D0FF86DQ24672491-FBBCD266-8452-4CBE-9F04-FFA6B458F3A7Q24676272-A66BA3CE-EE5A-4150-95AB-20484B237038Q24810256-72294941-F176-42AA-9075-CFA31F32185FQ27022422-31F8B2AF-5B8F-4B0E-B7AC-ACC853BA6992Q28080919-628A4174-A300-46BA-B75E-F6505456173FQ28238379-4A2B8BAC-EF04-4EA7-A414-0DF7AD70137DQ28924362-3FD7C187-F4BB-4057-B8E1-D4F0CB066F46Q30274598-25CF0464-09E7-48C0-97D2-5C6F04A46320Q30304153-E336144A-4246-47BB-B41B-BCF7051AC01EQ30305530-D80CEE3A-843D-4940-8963-F4DEA4B3ADF2Q30306583-BD8D8421-FB11-4400-9636-5147C89CBEB1Q30356689-84F60B0A-F9F6-4518-8B41-C57A0F7EAB87Q30371547-B31E4BED-1A24-4EBE-BBC6-781B5006C513Q30414892-7AD86877-4880-478E-B3D4-D8986FBA7EF7Q30433217-506ADD71-55F7-4923-B199-2C10F6052E9CQ30433911-DD1852B9-131D-4987-B6DD-4B494595C7CFQ30435893-D4778567-BB84-4F5F-A511-81527FBE394DQ30436358-5DACE50A-3425-4AB6-A281-81E0A17ED0EFQ30436422-012F472F-775E-4032-990B-72C1C40A5235Q30438648-EDF9E1BD-F69F-4AC4-941B-7E2092777754Q30442820-738EE165-B2CD-45F0-8313-E85FC64A6CADQ30444065-9EA9DC13-45B4-4628-92F4-01FD8CF561D9Q30469630-BCD9DFA0-D660-4E00-AA76-07BD2887E444Q30697033-63A43425-BC3C-4FBC-A8FA-D907815D0EC5Q33215044-070AB401-65B8-44B7-BA3D-507D8F08AFDEQ33222048-061FE810-458B-496F-9223-BCB603ADC4B2Q33255244-97C64C7B-50BC-4E76-97C0-9FFC1FADCCD8Q33303325-998848CA-7C25-440F-9FAA-6C807A03D59DQ33344607-2A8AEEAD-3F72-42CA-9E5C-299CF07A1C35Q33530815-CE2D90F7-BD1F-429D-8615-2CD3521073DBQ33582318-4D183546-946F-45D4-AED2-26BC4A9C3E27Q33631854-F1BFEAC7-2875-43ED-B907-B56AF639B86DQ33776127-88668375-6886-4551-B4D5-6E29BEA95085Q33815369-E8794D45-4F67-4100-A326-FC98C8FBEA73Q33815374-D40A8691-3DD4-489F-84D8-A9D204B1DBCAQ33824207-703B822F-8267-4625-84EF-7BE473C80D9FQ33827458-FE93BAB4-98BE-4327-A85D-FAD6C70768FD
P2860
An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins
description
1996 nî lūn-bûn
@nan
1996 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
An HLA-A2-restricted tyrosinas ...... rocessing of membrane proteins
@ast
An HLA-A2-restricted tyrosinas ...... rocessing of membrane proteins
@en
type
label
An HLA-A2-restricted tyrosinas ...... rocessing of membrane proteins
@ast
An HLA-A2-restricted tyrosinas ...... rocessing of membrane proteins
@en
prefLabel
An HLA-A2-restricted tyrosinas ...... rocessing of membrane proteins
@ast
An HLA-A2-restricted tyrosinas ...... rocessing of membrane proteins
@en
P2093
P2860
P356
P1476
An HLA-A2-restricted tyrosinas ...... rocessing of membrane proteins
@en
P2093
C L Slingluff
J C Skipper
J Shabanowitz
P H Gulden
R C Hendrickson
V Brichard
P2860
P304
P356
10.1084/JEM.183.2.527
P407
P577
1996-02-01T00:00:00Z